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Abstract
Background: Vaccination is a key component to public and personal preventative health. The
COVID-19 pandemic has illuminated the need for further research into how best to encourage
vaccination, especially in harder to reach or vulnerable populations.
Purpose: This project sought to evaluate beliefs and perceptions of the flu vaccine in the context
of the COVID-19 pandemic and to explore the views of the project site’s population in order to
develop more targeted educational programs for increasing flu vaccination. The project focused
on the ambulatory population of the emergency department.
Methods: The survey tool administered was based on the National Flu Survey to evaluate
potential numbers of vaccination and rationale if participants choose to decline vaccination. It
was administered to adult English-speaking patients in an urban academic medical center
emergency department and then the survey was analyzed for differences in attitude between
specific demographic groups. Data was collected via RedCap electronic data capture tools.
Results: A total of 69 patients participated in the survey. No correlation was found between
demographic data and the likelihood of being vaccinated for flu or COVID-19. The most
significant correlation was between previous flu vaccination and current vaccination for both flu
and COVID-19.
Conclusion: Previous vaccination indicates a willingness to seek future vaccinations in those
seeking emergency care. Future interventions should be focused on those who historically have
not been vaccinated.
Keywords: Flu vaccine, COVID-19 vaccine, beliefs and perceptions
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Perceptions of the Flu Vaccine in the Setting of Covid-19
Introduction
Influenza and other viral respiratory infections cause thousands of infections and deaths
each year. Patients with comorbidities are at significantly higher risk of complications and death
from the flu than healthy individuals. While the influenza vaccine has been widely available at
minimal cost for decades, people are still very hesitant to receive it (Barberis et al., 2016; NORC
at the University of Chicago [NORC], 2020). As of 2020, even in the setting of a global
pandemic, over one third of Americans did not intend to receive a flu vaccination for the season
(NORC, 2020).
While that number alone is daunting, each person has their own individual reasons for not
wanting to get a flu vaccine. Individual reasons, as explored by numerous researchers, can be
sorted into three categories: misinformation about the vaccine, misinformation or mistrust of the
medical and pharmaceutical communities, and lack of resources or availability to receive the
vaccine (Athota, 2016; Beers et al., 2019; Buechler et al., 2020; Freimuth et al., 2017; Kong et
al., 2020; Lutz et al., 2020; Olanipekun et al., 2020; Wooten et al., 2012). \
These reasons vary by community. Understanding the community and their specific
needs and rationale for declining vaccination can lead to the development of more targeted
interventions for specific populations. This project focuses on the development of an emergency
department based vaccination program for improved access to vaccines and other preventative
health measures for patients who may interact with the medical system most frequently in the
ED.
Background
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Influenza and pneumonia are the seventh leading cause of death in the state of
Massachusetts (Centers for Disease Control and Prevention [CDC], 2021). Even though a
leading cause of death, adults have a vaccination rate of only 44% (Massachusetts Department of
Public Health [MA DPH], 2021). High risk adults, defined as those with asthma, heart disease, or
diabetes, have vaccination rates between 42% and 46% while those aged 65 or older are
vaccinated at approximately 58% of the total population (MA DPH, 2021). Adults suffering from
social hardship factors, such as homelessness, are additionally more likely to be unvaccinated but
have a higher likelihood of contracting influenza or a flu-like illness (Rogers et al., 2019).
Problem Statement
By evaluating beliefs, perceptions, and demographic factors that impact access and desire
to receive flu vaccination, public health and medical organizations can devise better programs to
provide for the most vulnerable patients where they most commonly encounter and engage with
the medical system. In addition to the primary goal as stated, this project additionally seeks to
better understand changes in patient beliefs and perceptions in the setting of the SARS-COV-2
(COVID-19) pandemic.
Analysis of the Project Site
At present, the large urban academic medical center emergency department where this
project was conducted sees over 100,000 individual patients annually (Aaronson et al., 2019).
As is typical in emergency settings across the US, many patients present to the ED when they do
not have a primary care provider and need what may be considered non-emergent medical care
(Beers et al., 2019). The project site is associated with a free flu clinic that is open one day per
week during flu season and operates out of a conference room below the ED, however it is not
typically mentioned to patients during their ED visit. The goal of this project was to understand
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the perception of flu vaccination in the changing climate of the COVID-19 pandemic and
provide additional data for more targeted public health measures, like vaccination, for the project
site’s specific population.
Review of the Literature
Methods
Inclusion criteria for this review of literature were fairly broad including: articles
published 2012-2022, written in English, and included search terms “flu vaccine,” “influenza
vaccine,” “homeless,” “emergency department,” and “emergency department vaccination.” The
beliefs and perceptions of the flu vaccine, or the factors, both personal and demographic, that
influence vaccination uptake were of particular interest.
Several databases were used to identify articles that fit the above criteria. CINAHL,
PubMed, Cochrane, and Google Scholar all returned articles fitting the above specifications. A
total of 25 articles were selected due to their relevance to the mentioned criteria.
Major Themes
The selected studies were found to fit into one of four thematic categories: vaccine update
in underserved populations, vaccine beliefs and perceptions, interventions to increase vaccination
uptake, and efficacy of emergency department based vaccination programs.
Flu Vaccinations in Homeless and Underserved Populations The first theme noted
was that of uptake of vaccines in homeless or other underserved populations in the US. This
included five of the 25 selected studies. In their study, Beers, Filter, and McFarland explored
offering vaccines to homeless individuals at nontraditional vaccine administration sites (2019).
The researchers found that interventions at locations other than the health center saw increased
vaccination rates while the medical center rates did not improve (Beers et al., 2019). In an
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epidemic situation, Buechler et al. examined the beliefs and perceptions of the homeless in
regard to hepatitis A vaccination. They found that 41% of subjects felt that they had difficulty
accessing vaccination resources and 30% of subjects felt that the population in general was fully
vaccinated, indicating a need for further efforts for vaccination outreach and accessibility
(Buechler et al., 2020).
In Germany, similarly to Buechler et al.’s Detroit study, Bohmer et al. evaluated barriers
to vaccination post-pandemic (2012). This study determined that while subjects in high risk
groups or from higher socioeconomic status were more likely to receive a flu vaccine, post
pandemic vaccination rates were far below target coverage numbers (Böhmer et al., 2012). This
same study identified two main reasons for subjects not being vaccinated: fear of side effects,
and a belief that vaccination is not necessary (Böhmer et al., 2012).
Kong et al. conducted a similar study in Australia, evaluating the factors that impact flu
vaccine uptake in hard-to-reach populations including the homeless (2020). They determined that
outreach and increasing accessibility to vaccines for these populations results in significant
improvements in vaccine uptake (Kong et al., 2020).
Perceptions and Beliefs about Flu Vaccinations The second theme consisted of
perceptions and beliefs regarding a person’s decision to receive a flu vaccine. In a 2016 doctoral
dissertation, Athota evaluated the effect that personal beliefs and perceptions had on an elderly
patient’s likeliness to get a flu vaccine (2016). Findings from this dissertation determined that
vaccination rates in elderly patients can vary significantly based on the patient’s ethnic
background, with Hispanic and African American patients reporting significantly lower rates of
vaccination than European Americans (Athota, 2016). These patients also exhibited differences
in their likelihood to get vaccinated even if they believed that the vaccine was effective and safe
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(Athota, 2016). Athota’s study also determined that recommendation from a healthcare provider
had a significant positive impact on a patient’s probability of getting vaccinated (2016).
Buechler et al., in comparison to Athota’s broad survey of elderly adults, focused on the
homeless population in Detroit (2020). This study actually fits into multiple categories due to the
emphasis on beliefs in the homeless population (Buechler et al., 2020). The Detroit study
concluded that the homeless population who exhibited vaccine hesitancy fell into one of two
categories: those concerned for side effects or illness from the vaccine itself, and those who did
not trust in the intentions of the medical or pharmaceutical communities (Buechler et al., 2020).
In the case of those concerned about the physical effects of the vaccine, researchers found that
educational materials and discussions with providers were often enough to convince the patient
to accept a vaccine while those who did not trust the medical establishment or vaccine
manufacturers would often continue to decline vaccination (Buechler et al., 2020).
Wooten et al. conducted a similar study to Athota’s, with similar results: flu vaccination
behavior in elderly patients is affected by the outreach and influence of the patient’s medical
providers (Athota, 2016; Wooten et al., 2012). Both studies also identified disparities in
vaccination beliefs and uptake rates between different ethnic and racial groups, indicating that
more work must be done to ensure equitable care for all patients (Athota, 2016; Wooten et al.,
2012).
Distilling beliefs and perceptions down to the simplest components, Freimuth et al.
evaluated the role of risk perception in vaccine acceptance of African American and white adults
in the United States (2017). The findings here echoed those of others, determining that those who
felt themselves at lower risk of illness or death from the flu were less likely to get vaccinated
(Freimuth et al., 2017).
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Interventions to Increase Vaccination Uptake A third theme of articles included those
evaluating interventions to increase flu vaccination rates in various patient populations. Many of
these studies overlap with those in the other categories, such as those by Thomas and Lorenzetti
in 2018 and Wooten et al. in 2012. Both of these studies examined factors that influence flu
vaccination rates in elderly patients in the United States (Thomas & Lorenzetti, 2018; Wooten et
al., 2012). Wooten et al. determined that interventions need to be tailored to specific populations
with emphasis on addressing disparities. Similarly, Kong et al. found that hard-to-reach patients
responded to outreach programs that made care more readily available and focused on their
needs (2020).
Efficacy of Emergency Department Based Vaccination Programs The final theme
was composed of studies evaluating the efficacy of emergency department based vaccination
programs. This category was included in the literature review due to the proposed project site
being an emergency department. In a paper published by the American Academy of Emergency
Medicine and reviewed by the clinical guidelines committee, Abraham et al. explored the
prevention, diagnosis, and treatment of vaccination in the emergency department (2016). In the
published guidelines, vaccination is included as a recommendation to prevent infection in
patients who present to the ED and have not yet been vaccinated for the year (Abraham et al.,
2016). Putting this guideline into action, Baumer-Mouradian et al. implemented a mandatory
screening for all patients presenting to the pediatric ED (2020). By implementing mandatory
screening instead of optional, the researchers found that parents were interested in having their
children vaccinated while in the ED for other reasons, if offered the opportunity (BaumerMouradian et al., 2020).
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One significant barrier to ED-based vaccination programs like the ones above is concern
for time-based metrics. This concern has been disproved by Casalino et al. in 2018. They
determined that initiating an ED based flu vaccination program allowed for increased coverage
without significant impact to important time metrics including length of stay (Casalino et al.,
2018). Hart et al. also evaluated the efficacy of ED vaccination programs, but in terms of cost
instead of time (2018). They found that offering flu vaccinations in the emergency department
resulted in $114 of averted flu care costs (Hart et al., 2018).
Evidence-Based Practice
As evidenced by the above studies, as well as some older works like those of Slobodkin
et al. in 1998, Cox et al. in 2000, Rimple et al. in 2006, Molinari et al. in 2007, Martin, Brauner,
& Plouffe in 2008, and Morrison in 2009, influenza is a public health hazard, especially to those
at increased risk from medical or social comorbidities. The state of homelessness alone puts
individuals at increased risk of death, independent of other factors (Morrison, 2009). Homeless
individuals also tend to have higher rates of chronic illness, smoking, and illicit substance use,
putting them at high risk for complications from influenza (Story et al., 2014). Additionally,
many of the homeless patients and patients in underserved populations tend to use emergency
departments as a source of primary care (Lin et al., 2015). Since many of these patients tend to
interact mostly with the health care system in the ED setting, evaluating the patient population
for specific needs and providing information about local resources helped to improve access to
vaccination for underserved patient populations.
Theoretical Framework/Evidence-Based Practice Model
This project used the evidence-based practice model of the plan-do-study-act (PDSA)
method (Taylor et al., 2014). This method, a “four-stage cyclic learning approach” allows for
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multiple cycles in order to achieve a viable and continuously improving and adapting solution to
a problem (Taylor et al., 2014). The PDSA method also incorporates significant weight to each
stage of a cycle in order to improve with each repetition. In applying the PDSA method to this
vaccination project, the first phase focused on obtaining the necessary data to develop
increasingly more involved interventions for the site in the future.
In the planning phase of this project, a survey modeled on NORC’s annual survey of
intention to get a flu vaccine was adapted to better capture both flu and COVID-19 vaccine
beliefs and intentions, as well as to provide more detailed information on the needs and specific
demographics of the site’s patient population (NORC, 2020). This survey was then administered
to the patient population at the approved project site, in order to better understand their
vaccination beliefs and practices.
The do phase of the project, as well as the study and act phases, would be additional
projects, to be completed after data collection and a thorough development of an ED based
vaccination program.
Goals and Objectives
This project was the first step towards the ultimate goal of creating an ED based
influenza vaccination program. To that end, the goal of this first project was to gain better
understanding of the ED patient community’s beliefs and perceptions surrounding flu
vaccination in the setting of the global COVID-19 pandemic. The information gathered during
this project provided demographic information for the ED to use in planning further
interventions and programs for vaccination and other important health measures based on the
project site’s specific patient population that utilizes the ED. In several rounds of the PDSA
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model, continued exploration of the population’s beliefs and perceptions as well as resource
deficits could lead to development of additional ED based public health initiatives.
Methods
Project Site and Population
The project site was the emergency department at a large urban academic medical center.
The ED sees over 100,000 patients annually (Aaronson et al., 2019). The patient population of
the large academic medical center includes patients from over 140 countries and speaking over
128 languages (Massachusetts General Hospital Public Relations Staff [MGH PR Staff], 2021).
These patients, especially from surrounding communities, include immigrants (30%), those who
speak languages other than English at home (40%), and those whose household income is below
the poverty line (20%) (MGH PR Staff, 2021).
Measurement Instruments
The survey administered was based on the National Flu Survey (NFS) used by NORC at
the University of Chicago in collaboration with the CDC to evaluate potential numbers of
vaccination and rationale if participants choose to decline vaccination (2020). The tool is
available online for participant access. The NFS questions were altered only in the substitution of
the COVID-19 vaccine for the flu vaccine in those specific questions. The survey questions and
demographic questions can be found in appendices A and B.
Data Collection Procedure
The subject group was composed of a convenience sample of patients in the emergency
department in September and October 2021. The patients were approached by the DNP student
during their ED visit and invited to participate in the survey. Additionally, flyers located around
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the department invited patients who have mobile devices to access the survey via their device
(appendix F).
If the patient decided to participate in the survey, the subject was then offered a paper
survey or a QR code for the electronic version. The subject then filled out the survey and either
returned it to the primary investigator or submitted it to the online survey capture tool. If the
subject indicated at the end of the survey that they would like information and resources related
to the vaccine and where to receive one, a separate sheet was provided in paper and electronic
formats (appendix E).
The data were collected and managed using REDCap electronic data capture tools hosted
at the approved project site, a large academic medical center. REDCap (Research Electronic
Data Capture) is a secure, web-based software platform designed to support data capture for
research studies, providing 1) an intuitive interface for validated data capture; 2) audit trails for
tracking data manipulation and export procedures; 3) automated export procedures for seamless
data downloads to common statistical packages; and 4) procedures for data integration and
interoperability with external sources (Harris et al., 2019).
Data Analysis
All data collected during the two-month survey period was exported from RedCap to
SPSS for analysis. The data were cleaned of any nonsensical data and then assessed using
descriptive statistics and Pearson’s R correlations to identify any trends between vaccine
perceptions and demographic data. All data was evaluated for significance at p=0.05.
Ethical Considerations and Protection of Human Subjects
The University of Massachusetts, Amherst (UMass) Internal Review Board (IRB)
approval was obtained prior to initiating the DNP project. This project was undertaken as a
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Quality Improvement Initiative at the approved academic medical center, and as such was not
formally supervised by the Institutional Review Board per their policies. Participation of all
subjects was completely voluntary, with an option to refuse any or all questions at the
participant’s discretion. Paper surveys that did not include any identifying information were
administered by the primary investigator only and kept in a secured location accessible only by
the primary investigator. Online survey responses were also be accessible only by the primary
investigator. There was no physical component or risk of harm to the subjects. All participants
were provided the opportunity to speak with the primary investigator for support at their request
in the event that the survey contents cause any unforeseen emotional distress. Participants were
also be offered vaccination information and locations to receive vaccination at their request
(appendix E).
Timeline
The timeline for this project was two months of data collection in October and November
2021 (appendix C). After the data collection period, all survey data was compiled and sorted
over the next two months, December 2021 and January 2022. Data review, analysis, and
interpretation took place in January and February 2022.

Results
This project evaluated the beliefs, perceptions and demographics of a sample of adult
emergency department patients in a large urban academic medical center. In total, 70 patients
participated in the survey over a period of 2 months. The participants were encouraged to
participate via QR code or paper survey after seeing the code on flyers around the ED or being
approached by the DNP candidate.

16
Figure 1
Participant Demographics
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The population of non-critical, English-speaking patients in the emergency department,
were primarily ages 18-29 (43.5%, n=30) years, but covered all ages including 75 years and
older. A majority of patients who participated in the survey identified as female (56.5, n=39) and
40.6% (n=28) identified as male. Subjects spanned all levels of education, with the majority
having a bachelor’s degree or equivalent (34.8%, n=24). The next most common level of
education was a graduate degree or equivalent (17.4%, n=12). Subject demographics also
indicate a primarily white (76.8%, n=53), non-Hispanic or Latinx (86.8%, n=59), and privately
insured patient population (62.3%, n=43). In the overall population, a majority also reported
having a primary care provider (78.3%, n=54). Figure 1 presents the breakdown of participants
by basic demographic characteristics.
Figure 2
Flu and COVID-19 Vaccination Rates 2021-2022

Figure 2 displays the breakdown of subjects who have either been vaccinated or intended
to be during the season. Of the 69 survey participants, 38.6% (n=27) had already received a flu
vaccine for the 2021-2022 season. An additional 58.1 (n=36) responded that they were planning
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on receiving a flu vaccine in the next four months of the season. In total, 90% of the surveyed
subjects (n=63) indicated that they have or will receive a flu vaccine during the 2021-2022 flu
season.
A similar number of respondents endorsed already having received a COVID-19 vaccine
at 94.2% (n=65). Of the remaining subjects, 84.3% indicated that they plan to receive a COVID19 vaccine (n=6). This later number also includes one participant who indicated both having
received a vaccine and was also planning on getting one.
For those who did not receive a vaccine and were not planning on receiving either
vaccine, the data show some slightly different rationale based on the type of vaccine.
In the flu vaccine rationale question, respondents indicated that they typically do not get
the flu (20%, n=4) or do not get sick (10%, n=2). Others indicated a concern over the risk of
contracting influenza from the vaccine (20%, n=4) or the risk of other side effects from the
vaccine (20%, n=4). Additionally, 45% of subjects indicated other reasons for not receiving the
flu vaccine, in addition to the ones listed (n=9). Two subjects indicated a health condition that
precludes them from being vaccinated against the flu (10%) and a further one marked having or
knowing someone who had a negative reaction to the flu vaccine in the past (5%).
Regarding the COVID-19 vaccine, patients indicated other reasons for their decision to
decline immunization. In their rationale for declining a COVID-19 vaccine, no subjects indicated
feeling as though they do not get sick or are unlikely to contract COVID-19. Instead, of the five
patients who indicated that they do not plan to receive the vaccine, 80% (n=4) indicated concerns
over either contracting the disease or side effects from the vaccine. Another subject indicated
that they did not believe that the vaccine worked (20%, n=1). An additional subject indicated that
they already had COVID-19 and therefore did not need to be vaccinated (20%, n=1). Two
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subjects also indicated other reasons than those included as a reason for not receiving a COVID19 vaccine (40%).
Figure 3
Past and Present Flu Vaccination Status

Patients who had received the flu vaccine during the previous flu season (2020-2021)
were more likely to have already received a flu shot for the 2021-2022 season (Pearson
correlation .372, p<0.01). This correlation is demonstrated in figure 3, above.
Figure 4
Past Flu and COVID-19 Vaccination Status
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These subjects were also more likely to get a flu vaccine if they had not already been
vaccinated (Pearson correlation .317, p<0.05). Subjects who had been vaccinated for flu in the
previous year were also more likely to have received a COVID-19 vaccine (Pearson correlation
.289, p<0.05), as illustrated in figure 4.
Interestingly, having received a flu vaccine during the 2021-2022 season was not
significantly correlated with having had a COVID-19 vaccine. When the data were analyzed,
there were no significant relationships found between age, race/ethnicity, levels of education,
insurance, transportation, or having a primary care provider and the likelihood of the respondent
having had a flu or COVID-19 vaccine or intending to receive one.
Additionally, fewer than half those surveyed indicated that the current COVID-19
pandemic had any influence on their flu vaccination status.
Of the survey respondents, less than half indicated that COVID-19 has made them more
likely to receive a flu vaccine (43.9%, n=29). An additional 39.4% indicated no change in their
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decision to be vaccinated against influenza because of COVID-19 (n=26). Four subjects
indicated that COVID-19 decreased their interest in getting the flu vaccine (6.1%). A further four
respondents stated that they did not know if COVID-19 had any impact on their flu vaccination
decision and two subjects declined to respond.
The one key finding in this project was that past flu vaccination was a positive predictor
of current and future flu and COVID-19 vaccination.

Discussion
The initial purpose of this study was to create an ED-based vaccination program for
influenza and then for COVID-19. Vaccination programs have been successful in other EDs for
decades (Abraham et al., 2016; Baumer-Mouradian et al., 2020; Casalino et al., 2018; Hart et al.,
2018; Kong et al., 2020). Due to several factors including logistics between nursing pharmacy,
and ordering providers, this project needed to be simplified. To that end, the first step in the
process of developing a program for the ED was to determine what factors influenced whether
someone was interested in receiving a vaccine.
As mentioned, the demographic distribution of survey participants was more than half
white, female, and with advanced education. This data should be compared to demographics
collected by the hospital to ensure a representative sample was achieved prior to making
inferences based on the survey population.
The one significant factor found through analysis was that previous vaccination had a
positive correlation with future vaccination behaviors. Patients who reported previously being
vaccinated were more likely to receive vaccination in the future, not just for influenza but for
COVID-19 as well.
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These results appear consistent with those found by Lutz et al. in 2017 and 2018 when
they examined factors associated with perceptions of vaccine safety and efficacy. They, and
others, also determined that recommendation by a health care provider significantly increased the
willingness of a patient to receive a vaccine (Lutz et al., 2020; Olanipekun et al., 2020).
Risk perception, studied by Freimuth et al., also played a role in a patient’s decision to be
vaccinated against the flu (2017). Freimuth et al. found that patients who perceived themselves to
be at higher risk of becoming ill from the flu were more likely to be vaccinated (2017).
The current project, still in the planning phase of the PDSA model for creating an ED
based vaccination program, found that only slightly more patients (43.9%, n=29) thought that the
current COVID-19 pandemic made them more likely to get a flu vaccine than in previous years.
Further study could be undertaken using a model similar to that of Freimuth et al. to evaluate
whether patients who declined vaccination also did not perceive themselves to be at high risk of
illness from COVID-19.
In the context of a Plan-Do-Study-Act framework, this project is the first part of the
planning phase. Using the data gathered from this study will inform the next step, the creation
and implementation of an ED-based vaccination program. The significant correlation between
previous vaccination and current and future intention to be vaccinated indicates a need to focus
efforts on those who have historically declined vaccination according to their records.
Setting Facilitators and Barriers
The project site itself included a significant number of facilitators to this study. The large
academic presence, research-friendly culture, supportive environment, and a patient population
that is familiar with the ongoing research and improvement projects made approaching staff and
patients for inclusion straightforward. Additionally, the project site allowed for the placement of
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flyers with QR codes to invite patient participation, even when the primary investigator was not
on site.
Barriers to the project initially included the participation of patients who were in the
emergency department for care and might not be interested in filling out a survey. Interestingly,
the political climate surrounding the COVID-19 pandemic also became a barrier to patient
participation. When approached to participate in the survey, some patients and their visitors
instead wanted to engage in political discussions regarding the safety and efficacy of the
COVID-19 vaccines, as well as the origins and theories about the disease itself. The DNP student
had to explain many times that the vaccines themselves were not being studied at the current
time by this investigator or the subject of the current project. After redirection from the
aforementioned political topics, the patients generally did not want to be included in the survey.
Conclusion
Influenza is a highly communicable disease with a significant financial and
socioeconomic impact. Vaccination is approximately 60-78% effective at preventing influenza
and serious health consequences of influenza infection (Abraham et al., 2016). This project
evaluated the factors that comprise an individual’s decision receive or decline flu and COVID-19
vaccination, as well as any relationship the pandemic may have had on flu vaccination. While
this project found a common thread in those who have been previously vaccinated continuing to
see out vaccination, there were some significant limitations to this project, as well as many
avenues open for future exploration and study.
Limitations
One significant limitation was time and the ability to reach a larger sample of patients.
The ED site used sees well over 100 patients per day so the 69 who completed the study survey
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are not necessarily a representative sample for the true ED population. Another was the
willingness of ED patients to participate. This could be due to their illness or injury that
prompted them to present to the ED. Patients could also have elected to not participate because
they had already received a flu vaccine or COVID-19 vaccine and did not understand the
purpose of the project.
Another, unforeseen limitation, was the skew in demographics by those willing to
participate and those who were not. As mentioned above, the most prevalent demographics in the
survey sample were higher education, white, and female. This trend would be a worthwhile
avenue for further study in order to better understand the whole target population, not just this
group. One theory is that of the politicization of vaccination and disease prevention during the
COVID-19 pandemic. The DNP student had many conversations with patients about potential
participation in the survey, only to be told by the patient or their family that they did not believe
in the COVID-19 pandemic or vaccine. When the DNP student attempted to elaborate on the
purpose of the survey and its implications on the ED, the patient or family continued to discuss
the COVID-19 pandemic, citing a lack of belief in the safety of COVID-19 vaccines specifically,
or occasionally, other concerns regarding COVID-19 or vaccinations in general. Even after
several explanations about the purpose of the project and reassurances that no vaccinations
would be given, the patients and families continued to decline to participate, so this portion of
the population was generally lacking from the final data set.
The data set was not analyzed via multivariate methods to isolate each specific
demographic factor against vaccination status, rather each demographic descriptor was handled
individually. More research and analysis would be necessary to fully explore the implications of
each demographic grouping within the sample population, provided the population is accurately
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representative of the ED’s patients in general. Additional multivariate analyses of the data could
provide a much more thorough evaluation of the ED population and their vaccination status
while controlling for each individual demographic. However, this would have been more reliable
and accurate with a larger sample.
Additionally, the survey was only conducted in English. While some patients did indicate
that their primary language was something other than English, they did need to be able to read
and understand English in order to participate in this project.
Further Research
The significant results of this project, the positive correlation between previous flu
vaccination and future vaccination behaviors, provide several avenues for future research, both in
the ED setting and in a broader context. In the ED setting, there exists an opportunity to explore
methods of encouraging patients to participate in preventative health care like vaccination while
they are engaged with the healthcare system. In a broader sense, closer examination of
demographics and vaccination patterns can help with public health and safety, as well as disease
prevention in the future.
With the impact of the COVID-19 pandemic not yet fully explored and understood, much
work remains to be done to fully realize and comprehend all the factors that comprise an
individual and a population’s decision to receive or decline a vaccination.
Cost-Benefit Analysis
In addition to the future research and potential to reach additional patients for
vaccination, the aim of the project could eventually have financial implications for the project
site and patient care as well. According to the Centers for Disease Control and Prevention
(CDC), a single dose of a quadrivalent influenza vaccine costs between $13.04 and $26.39 for
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the intramuscular injectable formulation. The intranasal live attenuated quadrivalent vaccine
costs between $16.45 and $23.70. The variability in cost is related to brand and CDC or private
sector pricing.
The cost of influenza however, can be measured in dollars, lives, and socioeconomic
impact. Twenty years ago, Cox et al. (2000) estimated the cost of treating influenza in the ED to
be around $141.89 for a patient who was discharged home from the ED and $3,251.04 for
patients requiring admission to the hospital. Adjusted for inflation, influenza costs an ED
approximately $221.08 for a discharged patient and $5,065.57 for an admitted patient (BLS,
2021). Annually, influenza costs the United States (US) $13.4 billion in direct medical costs,
when adjusted for inflation from Molinari et al.’s 2007 study. Indirect medical costs, including
lost earnings related to illness or death amount to $21 billion (Molinari et al., 2007; US Bureau
of Labor Statistics [BLS], 2021). In addition to the financial aspect, influenza accounts for more
than 31.4 million outpatient visits and over 3.1 million hospitalized days per year (Molinari et
al., 2007).
In comparison to the cost of influenza or even providing vaccination, the financial
implications of surveying patients for interest in vaccination and providing information and lists
of resources for patients were negligible. The survey was offered both on paper and online. In the
case of a paper survey, the only cost was the ink and paper on which the survey is printed. The
primary investigator was on site to administer surveys at no cost to the project site. The online
survey was created on REDCAP, the tool used by the project site for data capture, by the primary
investigator in order to collect, store, and export data. Analysis of the exported data was also
conducted by the primary investigator at no cost to the project site. Based on the cost of
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vaccination against the cost of influenza infection or other disease infection, further exploration
of this topic could reduce the cost of influenza or even COVID-19 infection in money or lives.
Ultimately, the best predictor of future vaccination was previous vaccination.
Demographic data appeared to have an impact on this decision for the sample from a large urban
academic medical center emergency department insofar as patients self-selected for participation
based on previously discussed, generally political, factors. This project was just the first step
towards creating a departmental program for offering vaccination to patients during their
admission. The data gleaned from this first survey revealed that future interventions should focus
on those who typically do not get vaccinated for flu annually. Additionally, research can be done
on those who elected not to be vaccinated and not to participate in the survey, citing concerns
about the pandemic or vaccines in general. More research is needed to fully explore this complex
topic and develop further public health initiatives within the ED setting.
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Appendix A
Flu and COVID Survey
1.) Have you had a flu vaccine (nasal mist or shot) in the past three months?
a.) Yes (skip to question 4)
b.) No
c.) I don’t know
2.) Are you planning on getting a flu vaccine (nasal mist or shot) in the next four months?
a.) Yes
b.) No
c.) I don’t know
3.) If you are not planning on getting a flu vaccine this year, please indicate how you
made your decision?
a.) I never get the flu
b.) I am not likely to get very sick from the flu
c.) I am allergic to the flu vaccine
d.) I do not like needles
e.) I, or someone I know, had a bad reaction to the flu vaccine in the past
f.) I do not have time to get the vaccine
g.) I am concerned about getting the flu from the vaccine
h.) I am concerned about other side effects from the vaccine
i.) I have a health condition that prevents me from getting the vaccine
j.) I do not think the vaccine works
k.) I think the vaccine costs too much
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l.) I do not have a way to get to a vaccination site
m.) Other _____________________
4.) Did you get a flu vaccine (nasal mist or shot) last year (Sept 2020- Feb 2021)?
a.) Yes
b.) No
c.) I do not know
5.) Did you get your child(ren) vaccinated for flu this past season, in the last 3 months?
a.) I do not have children under age 18
b.) Yes
c.) No
d.) I do not know
e.) Prefer not to respond
6.) Do you plan on getting your child(ren) vaccinated for flu this upcoming season, the
next 4 months?
a.) I do not have children under age 18
b.) Yes
c.) No
d.) I do not know
e.) Prefer not to respond
7.) Where have you gotten the flu vaccine in the past, if you have received the vaccine
before?
a.) Primary Care Office
b.) Workplace
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c.) Urgent Care
d.) Retail Pharmacy (CVS, Walgreens, Rite Aide, etc)
e.) Public health clinic
f.) Hospital
8.) Have you gotten a Covid-19 vaccine?
a.) Yes (proceed to question 11)
b.) No
c.) I do not know
9.) Are you planning on getting the Covid-19 vaccine if you have not?
a.) Yes
b.) No
c.) I do not know
10.) If you have not already received the Covid-19 vaccine and are not planning on
getting it, what are the factors that influenced your decision (circle/check all that apply)?
a.) I never get sick
b.) I am not likely to get very sick from Covid-19
c.) I do not like needles
d.) I am allergic to the Covid-19 vaccine
e.) I had a bad reaction to other vaccines in the past
f.) I do not have time to get the vaccine
g.) I am concerned about getting COVID-19 from the vaccine
h.) I am concerned about side effects other than getting COVID-19 from the vaccine
i.) I have a health condition that prevents me from getting the vaccine
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j.) I do not think the vaccine works
k.) I think the vaccine is too expensive
l.) I do not think I need the vaccine because I have already had COVID-19
m.) I do not have access to a vaccination site
n.) Other _________________
11.) Has the COVID-19 pandemic made you more or less likely to get a flu vaccination
in the future?
a.) Yes, I am more likely to get a flu vaccine
b.) Yes, I am less likely to get a flu vaccine
c.) No, the COVID-19 pandemic has not influenced my opinion of the flu vaccine
d.) I do not know
e.) Prefer not to respond
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Appendix B
Flu and COVID-19 Vaccination Survey Demographics Section
This portion of the survey is intended to capture the demographics and needs of the MGH
patient community so that we may better address these in the future. Please respond to as many
of the questions as you are able. If you do not wish to answer a particular demographics
question, please indicate with the “prefer not to respond” option.
1.) What is your age?
a.) 18-29
b.) 30-44
c.) 45-59
d.) 60-75
e.) 75+
f.) Prefer not to respond
2.) What gender do you identify as?
a.) Male
b.) Female
c.) Non-binary
d.) Transgender male
e.) Transgender female
f.) Other ______
g.) Prefer not to respond
3.) What is your highest level of education?
a.) Some high school
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b.) High school diploma or equivalent
c.) Some college
d.) Associate’s degree or equivalent
e.) Bachelor’s degree or equivalent
f.) Some graduate studies
g.) Graduate degree or equivalent
h.) Post-graduate degree or equivalent
4.) What is your race/ethnicity?
a.) White
b.) Black and/or African American
c.) Asian
d.) Native Hawaiian, Native American, or Alaskan Native
e.) Pacific Islander
f.) Middle Eastern
g.) Other ________
h.) Prefer not to respond
5.) Do you identify as Hispanic or Latinx?
a.) Yes
b.) No
c.) Prefer not to respond
6.) What is your primary Language?
a.) English
b.) Spanish
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c.) Haitian Creole
d.) Chinese (Mandarin or Cantonese)
e.) Portuguese
f.) Other ________
g.) Prefer not to respond
7.) Where do you live?
a.) Boston
b.) Dorchester
c.) Chelsea
d.) Charlestown
e.) Roxbury
f.) Revere
g.) Watertown
h.) Suburb of Boston ________
i.) Other in MA
j.) Other state ________
k.) Other country _______
l.) Prefer not to respond
8.) What type of setting do you live in?
a.) Own house/condo/apartment
b.) Rent house/condo/apartment
c.) Shelter
d.) Homeless
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e.) Group home
f.) In transition
g.) Other _______
h.) Prefer not to respond
9.) What is your usual method of transportation
a.) Private vehicle (car/motorcycle/scooter/etc)
b.) Bicycle
c.) Public transit (MBTA, bus, train, amtrak, etc)
d.) The Ride
e.) Ride-share service (uber, lyft, taxi, zipcar, etc)
f.) Walk
g.) Other _______
h.) Prefer not to respond
10.) Do you have a primary care provider (MD, DO, NP)?
a.) Yes
b.) No
c.) I do not know
d.) Prefer not to respond
11.) Do you have a cell phone?
a.) Yes
b.) No
c.) I don’t know
d.) Prefer not to respond
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12.) Which type of insurance do you have?
a.) Private
b.) MassHealth
c.) Medicare
d.) Medicaid
e.) Combination of above
f.) None
g.) I don’t know
h.) Prefer not to respond
13.) Would you like resources and information about the flu and COVID-19 vaccines and
where to get vaccinated?
a.) Yes
b.) No
c.) Only information
d.) Only vaccine distribution locations
e.) Prefer not to respond
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Appendix C
Timeline
Table 1
Perceptions of the Flu Vaccine in the Setting of Covid-19 Project Timeline
Task
Complete proposal and seek
IRB approval
Complete online creation of
survey and associated QR Code
Administer survey

July

Aug

Sept

Oct.

XX

XX

Nov.

Dec. Jan.

XX

XX

Feb. Mar.

XX
XX

Analyze data
XX

Develop concusion

XX
XX
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Appendix D
Cost Benefit Analysis
Table 2
Vaccine vs. Illness Costs Table
Cost
Fluarix Quadrivalent

Vaccine
$18.13

Admitted Patient
$221.08

Discharged Patient
$5,065.57

47
Appendix E
Flu and COVID-19 Vaccine Resources
MA Residents
Covid-19 Vaccine Locations: https://www.mass.gov/info-details/covid-19-vaccinationlocations
Flu Vaccine Locations: https://www.mass.gov/info-details/influenza-vaccination

NH Residents
Covid-19 Vaccine Locations: https://www.vaccines.nh.gov/vaccination-locations
Flu Vaccine Locations: https://www.dhhs.nh.gov/dphs/cdcs/influenza/index.htm

General Vaccine Information
Covid-19 Vaccine Information Sheet: https://www.cdc.gov/vaccines/covid19/eua/index.html
Flu Vaccine Information Sheet: https://www.cdc.gov/vaccines/hcp/vis/visstatements/flu.pdf
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Appendix F
Flyer Inviting Patients to Participate in Survey Project
How do you feel about the flu shot? Has COVID-19 influenced your thinking about it?
Help our team better understand your vaccination and preventative health needs by
participating in our survey!

QR Code for Redcap Survey Here

This survey is a DNP project evaluating beliefs and perceptions of the flu vaccine during
the COVID-19 pandemic. Participation is voluntary and very appreciated.

Primary Investigator: Lauren Vogel-Hanley, RN, DNP Candidate UMass Amherst

